title: In reply.
authors: Washington University School of Medicine St. Louis, Missouri Albert Einstein College of Medicine Bronx, New York University of Alabama at Birmingham Birmingham, Alabama Emory University School of Medicine Atlanta, Georgia Kaiser Permanente Medical Group Sacramento, California.
authors: L Stewart
authors: LS
authors: Massad
authors: Mark
authors: M
authors: Einstein
authors: Warner
authors: W
authors: Huh
authors: Herschel
authors: H
authors: Lawson
authors: Walter
authors: W
authors: Kinney
mesh_terms: D000230:Adenocarcinoma / Q000473:pathology*; D002278:Carcinoma in Situ / Q000473:pathology*; D055088:Early Detection of Cancer / Q000592:standards*; D005260:Female; D006801:Humans; D002583:Uterine Cervical Neoplasms / Q000473:pathology*; D002578:Uterine Cervical Dysplasia / Q000473:pathology*
references: Massad LS, Einstein MH, Huh WK, Katki HA, Kinney WK, Schiffman M, et al.. 2012 updated consensus guidelines for the management of abnormal cervical cancer screening tests and cancer precursors. Obstet Gynecol 2013;121:829–846.